These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 12596758)

  • 41. Management of anemia.
    Rao M; Muirhead N; Buoncristiani U
    Contrib Nephrol; 2004; 145():69-74. PubMed ID: 15496793
    [No Abstract]   [Full Text] [Related]  

  • 42. The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.
    Schröder CH;
    Pediatr Nephrol; 2003 Aug; 18(8):805-9. PubMed ID: 12750985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythropoiesis stimulating agents (ESAs) for congestive heart failure: the red and the black.
    Robles NR; Macias JF; Herrera J
    Eur J Intern Med; 2014 Feb; 25(2):193-6. PubMed ID: 24491240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New treatments of anemia in chronic renal failure].
    Fernández Lorente L; Romero R
    Med Clin (Barc); 2014 Jul; 143(1):39-42. PubMed ID: 24467877
    [No Abstract]   [Full Text] [Related]  

  • 45. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of renal tubular damage with cardio-renal anemia syndrome in patients with heart failure.
    Otaki Y; Watanabe T; Takahashi H; Narumi T; Kadowaki S; Honda Y; Arimoto T; Shishido T; Miyamoto T; Konta T; Kubota I
    Int J Cardiol; 2014 May; 173(2):222-8. PubMed ID: 24630338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of chronic cardiorenal syndrome.
    Attanasio P; Ronco C; Anker MS; Ponikowski P; Anker SD
    Contrib Nephrol; 2010; 165():129-139. PubMed ID: 20427962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anemia and renal failure: efficacy of its control].
    Fort J
    Nefrologia; 2006; 26 Suppl 3():28-32. PubMed ID: 17469424
    [No Abstract]   [Full Text] [Related]  

  • 50. [The cardiorenal syndrome and erythropoietin].
    Kes P; Basić-Jukić N; Jurić I; Basić-Kes V
    Acta Med Croatica; 2008; 62 Suppl 1():21-31. PubMed ID: 18578329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of kidney disease and anemia in elderly, long-term care residents.
    Tangalos EG; Hoggard JG; Murray AM; Thomas DR
    J Am Med Dir Assoc; 2004; 5(4 Suppl):H1-6. PubMed ID: 15243310
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 53. [Complications of long-term hemodialysis patients and the countermeasures].
    Asano Y
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1273-8. PubMed ID: 1431471
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mediators of anemia in chronic heart failure.
    Le Jemtel TH; Arain S
    Heart Fail Clin; 2010 Jul; 6(3):289-93. PubMed ID: 20630403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalance of anemia and its association with cardio-renal syndrome.
    Silva RP; Barbosa PH; Kimura OS; Sobrinho CR; Sousa Neto JD; Silva FA; Silva Júnior GB; Mota RM; Daher EF
    Int J Cardiol; 2007 Aug; 120(2):232-6. PubMed ID: 17174420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of anemia in renal failure].
    Siciński A
    Pol Tyg Lek; 1974 Nov; 29(44):1895-8. PubMed ID: 4610533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.